It look like ZYL will not rise unless funding is sorted out. Must be patient with zyl with recommendation over 50 cents. Alway could buy more at 12.5 cent if you believe ZYL story.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025